MedPath

Pediatric Tuina for functional constipation in children: a randomized controlled clinical trail

Phase 1
Not yet recruiting
Conditions
Functional Constipation in Children
Registration Number
ITMCTR2100004859
Lead Sponsor
School of Second Clinical Medicine, Yunnan University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Children aged 1-7 years;
2. Children who meet the diagnostic criteria for functional constipation (Rome IV);
(1) Must include 1 month of at least 2 of the following in infants up to 4 years of age:
1) 2 or fewer defecations per week;
2) History of excessive stool retention;
3) History of painful or hard bowel movements;
4) History of large-diameter stools;
5) Presence of a large fecal mass in the rectum. In toilet-trained children, the following additional criteria may be used:
6) At least 1 episode/week of incontinence after the acquisition of toileting skills;
7) History of large-diameter stools that may obstruct the toilet.
(2) For children over 4 years of age, there must include 2 or more of the following occurring at least once per week for a minimum of 1 month with insufficient criteria for a diagnosis of irritable bowel syndrome:
1) 2 or fewer defecations in the toilet per week in a child of a developmental age of at least 4 years;
2) At least 1 episode of fecal incontinence per week;
3) History of retentive posturing or excessive volitional stool retention;
4) History of painful or hard bowel movements;
5) Presence of a large fecal mass in the rectum;
6) History of large diameter stools that can obstruct the toilet;
3. Parents or legal guardians are motivated to participate in the trial;
4. Parents or legal guardians' sign was written informed consent.

Exclusion Criteria

1. A history of intestinal surgery;
2. Receiving gastrointestinal prokinetic agent or laxative treatments 14 days before enrollment;
3. Receiving pediatric Tuina or probiotics 14 days before enrollment;
4. Children with Hirschsprung's disease;
5. Children with neurological and psychiatric disorders (e.g., cerebral palsy, autism, spina bifida, anorexia nervosa);
6. Children with any organic or metabolic diseases of hematopoietic, endocrine, immune systems.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath